Swiss Federal Institute of Technology Lausanne, EPFL

Swiss Federal Institute of Technology Lausanne, EPFL
Lausanne, Lake Geneva region
Web: Swiss Federal Institute of Technology Lausanne, EPFL
Location: Lausanne
Affiliated to : Conseil des EPF / ETH Rat
Related to:

EPFL is one of the two federal technical schools (university) in Switzerland. Like the ETH in Zurich, it has three missions: education of students, scientific research and technology transfer. EPFL is located near Lausanne on the shores of the Lake Geneva. It has a campus of more than 10,000 people. The school stimulates collaboration between students, professors, researchers and entrepreneurs. These daily interactions give rise to new and work in science, technology and architecture.

#display_name

Life Sciences Apr 20
In its first investment in EPFL, the Chan Zuckerberg Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, have awarded a research grant to the lab of Professor Bart Deplancke supporting the development of a web-based platform to analyze the transcriptome of single cells.
Social Sciences Apr 19

Algorithms are used to personalize our newsfeed on social media. But the risk is that the points of view we are presented with become increasingly limited and extreme.

Astronomy Apr 17
Astronomy

Using transmission electron microscopy, EPFL scientists have examined a slice from a meteorite that contains large diamonds formed at high pressure.

Medicine Apr 12
Medicine

Researchers from Campus Biotech were invited to develop joint projects with partner research institutes and bid for funding from the Bertarelli Foundation.

Computer Science Apr 18

The tactile joystick developed by startup Foldaway Haptics brings the sense of touch to mobile devices, drones and, in a smaller version, to virtual reality controls.

Event Apr 17

EPFL, PME Magazine and Le Temps are hosting a new type of forum aimed at supporting innovation in Swiss small and medium-sized businesses (SMEs).

Medicine Apr 11
Medicine

Researchers at EPFL and UNIL have discovered a dangerous liaison between immune cells that limits the efficacy of immunotherapy in melanoma.






website preview